Asenapine

Details

Files

Generic Name:

Asenapine

Project Status:

Complete

Therapeutic Area:

Bipolar I disorder

Manufacturer:

Lundbeck Canada Inc.

Call for patient/clinician input open:

December 2, 2011

Brand Name:

Saphris

Project Line:

Reimbursement Review

Project Number:

SR0262-001

Call for patient/clinician input closed:

January 9, 2012

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Bipolar I disorder

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

June 14, 2012

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : December 12, 2011